Close Menu

NEW YORK (GenomeWeb) – NanoString today said that its preliminary financial results for the fourth quarter and fiscal year ended December 31, 2018 are expected to beat its previously stated guidance, as well as the consensus Wall Street estimates.

NanoString said that product and service revenue is expected to be approximately $23.5 million for the fourth quarter of 2018, which would exceed the firm's previous guidance range of $22 to $23 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.